Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $15.76 and last traded at $15.91, with a volume of 975986 shares trading hands. The stock had previously closed at $16.03.
Analyst Upgrades and Downgrades
Several brokerages recently issued reports on WBA. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "hold" rating on the stock in a report on Wednesday, April 3rd. UBS Group cut their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a "neutral" rating on the stock in a report on Wednesday, April 3rd. SVB Leerink cut their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set a "market perform" rating on the stock in a report on Monday, March 18th. Morgan Stanley cut their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an "underweight" rating on the stock in a report on Monday, April 1st. Finally, Leerink Partnrs reaffirmed a "market perform" rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $24.36.
Get Our Latest Report on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Down 4.1 %
The company has a market capitalization of $13.27 billion, a price-to-earnings ratio of -2.23, a P/E/G ratio of 1.00 and a beta of 0.80. The business's 50-day moving average is $18.37 and its 200-day moving average is $21.12. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The firm's quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.16 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance, Inc. will post 3.22 earnings per share for the current year.
Walgreens Boots Alliance Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st will be given a $0.25 dividend. The ex-dividend date is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.50%. Walgreens Boots Alliance's dividend payout ratio (DPR) is currently -14.29%.
Insiders Place Their Bets
In other news, CFO Manmohan Mahajan acquired 6,000 shares of the firm's stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CFO Manmohan Mahajan bought 6,000 shares of the business's stock in a transaction dated Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares of the company's stock, valued at $3,235,859.22. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Inderpal S. Bhandari bought 3,000 shares of the business's stock in a transaction dated Thursday, April 11th. The shares were bought at an average cost of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company's stock, valued at $54,150. The disclosure for this purchase can be found here. Insiders own 17.40% of the company's stock.
Institutional Trading of Walgreens Boots Alliance
Institutional investors and hedge funds have recently modified their holdings of the stock. Verity Asset Management Inc. purchased a new stake in Walgreens Boots Alliance during the 1st quarter valued at about $411,000. Cetera Advisors LLC boosted its holdings in Walgreens Boots Alliance by 73.9% in the 1st quarter. Cetera Advisors LLC now owns 110,889 shares of the pharmacy operator's stock valued at $2,405,000 after purchasing an additional 47,136 shares during the last quarter. Cetera Investment Advisers boosted its holdings in Walgreens Boots Alliance by 89.8% in the 1st quarter. Cetera Investment Advisers now owns 349,464 shares of the pharmacy operator's stock valued at $7,580,000 after purchasing an additional 165,389 shares during the last quarter. Swedbank AB acquired a new position in Walgreens Boots Alliance in the 1st quarter valued at about $16,365,000. Finally, LRI Investments LLC acquired a new position in Walgreens Boots Alliance in the 1st quarter valued at about $145,000. Hedge funds and other institutional investors own 58.59% of the company's stock.
Walgreens Boots Alliance Company Profile
(Get Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Recommended Stories
- Five stocks we like better than Walgreens Boots Alliance
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- GameStop Will Rocket Higher: The Move Won’t Last
- Do ETFs Pay Dividends? What You Need to Know
- 3 Stocks Insiders are Buying That Should be on Your Radar
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Momentum Investing: A Guide to Getting Started
→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)
Should you invest $1,000 in Walgreens Boots Alliance right now?
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
20 Stocks to Sell Now
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
